Orphanet: Recherche par maladie / gène
x

Rechercher un projet de recherche

* (*) Champ obligatoire

43 Résultat(s)

Trier par

Financé par un membre IRDiRC =

Projets de recherche

ALLEMAGNE

Mecklenburg-Vorpommern
GREIFSWALD

Mutational spectra and clinical manifestation in patients with congenital haemophilia
Institut für Humangenetik der Universitätsmedizin Greifswald
Institut für Humangenetik

FRANCE

ILE-DE-FRANCE
LE KREMLIN-BICÊTRE

ITALIE

LOMBARDIA
MILANO

RBDD: Rare Bleeding Disorders Database network (coordination)
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Laboratorio di Patologie Molecolari Applicate alla Clinica

ALLEMAGNE

Baden-Württemberg
TÜBINGEN

AWISPECS: The role of acquired von Willebrand syndrome in cardiosurgical interventions in infancy
Universitätsklinik für Kinder- und Jugendmedizin Tübingen
Abteilung für Kinderkardiologie, Pulmologie, Intensivmedizin

AUTRICHE

WIEN
WIEN

Financé par un membre IRDiRCProspective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FRANCE

ILE-DE-FRANCE
PARIS

Mise en place du diagnostic prénatal non invasif des maladies monogéniques rares et sévères
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de génétique et biologie moléculaires

IRLANDE

County Dublin
DUBLIN

Financé par un membre IRDiRCIrish Personalised Approach to the Treatment of Haemophilia (iPATH)
Our Lady's Children's Hospital
Haematology Department

IRLANDE

County Dublin
DUBLIN

The Low Von Willebrand factor Ireland Cohort of Kids (LoVIC-K) study
Royal College of Surgeons of Ireland
Molecular and Cellular Theraputics

IRLANDE

County Dublin
DUBLIN

IRLANDE

County Dublin
DUBLIN

Financé par un membre IRDiRCIrish Personalised Approach to the Treatment of Haemophilia (iPATH)
St James's Hospital
National Coagulation Centre

ITALIE

LOMBARDIA
MILANO

Financé par un membre IRDiRCDevelopment of lentiviral vectors for liver gene transfer and application to hemophilia gene therapy
Istituto San Raffaele Telethon per la Terapia Genica - TIGET
Istituto San Raffaele Telethon per la Terapia Genica

JAPON

JAPAN
MIYAGI

Financé par un membre IRDiRCDevelopment of a predictive method for bleeding complication associated with intractable cardiovascular diseases with high shear-stress
Institute of Development and Aging and Cancer,Tohoku University
Department of Molecular and Cellular Biology

JAPON

JAPAN
MIYAGI

Financé par un membre IRDiRCDevelopment of management for acquired von Wilebrand syndrome complicated with mechanical circulatory support
Tohoku University Graduate School of Medicine
Department of Cardiovascular Surgery

SUISSE

Suisse Romande
GENÈVE

Molecular mechanisms and clinical consequences of variable fibrinogen levels
Centre Médical Universitaire - CMU
Département de médecine génétique et développement

ALLEMAGNE

Nordrhein-Westfalen
BONN

Enzymological and structural biology investigation on the function of the vitamin K cycle
Universitätsklinikum Bonn (AöR)
Institut für Experimentelle Hämatologie und Transfusionsmedizin

CANADA

Ontario
KINGSTON

Financé par un membre IRDiRCStudy of the factor VIII life cycle and its implications for factor VIII immunogenicity
Queen's University
Department of Pathology and Molecular Medicine

CANADA

Ontario
TORONTO

ESPAGNE

Comunidad Valenciana
VALENCIA

Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients
Hospital Universitario y Politécnico La Fe
Servicio de Farmacia, Área Clínica del Medicamento

ITALIE

UMBRIA
PERUGIA

Financé par un membre IRDiRCDissecting dendritic cell subsets as key to installing tolerance to FVIII in hemophilia A
Università degli Studi di Perugia
Dipartimento di Medicina Sperimentale

ROYAUME-UNI

Greater Manchester
ADDRESS: NOT PROVIDED - UK

Financé par un membre IRDiRCADVATE Hemophilia A Outcome Database (AHEAD) - UK
Institution: Information not provided - UK

Projets de recherche multicentriques